Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma

ClinicalTrials.gov ID: NCT05489887

Public ClinicalTrials.gov record NCT05489887. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jul 24, 2026, 10:10 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II Study of Naxitamab Added to Induction Therapy for Subjects With Newly Diagnosed High-Risk Neuroblastoma

Study identification

NCT ID: NCT05489887
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 2
Lead sponsor: Giselle Sholler; Other
Enrollment: 93 participants

Conditions and interventions

Conditions

Neuroblastoma

Interventions

Naxitamab Drug

Drug

Eligibility (public fields only)

Age range: 12 Months to 21 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Sep 13, 2022
Primary completion: Aug 31, 2029
Completion: Aug 31, 2036
Last update posted: Jun 30, 2026

2022 – 2036

United States locations

U.S. sites: 20
U.S. states: 16
U.S. cities: 20

Facility	City	State	ZIP	Site status
University of Alabama/Children's of Alabama	Birmingham	Alabama	35201	Recruiting
Arkansas Children's Hospital	Little Rock	Arkansas	72202	Recruiting
UCSF Benioff Children's Hospital Oakland	Oakland	California	94609	Recruiting
Rady Children's Hospital	San Diego	California	92123	Recruiting
Connecticut Children's Hospital	Hartford	Connecticut	06106	Recruiting
University of Florida	Gainesville	Florida	32611	Recruiting
Nicklaus Children's Hospital	Miami	Florida	33155	Recruiting
Arnold Palmer Hospital for Children	Orlando	Florida	32806	Recruiting
Augusta University Health	Augusta	Georgia	30912	Recruiting
Kapiolani Medical Center for Women and Children	Honolulu	Hawaii	96813	Recruiting
Norton Children's Research Institute/Affiliated with University of Louisville School of Medicine	Louisville	Kentucky	40202	Recruiting
Children's Hospital and Clinics of Minnesota	Minneapolis	Minnesota	55404	Recruiting
Cardinal Glennon Children's Hospital	St Louis	Missouri	63104	Recruiting
Levine Children's Hospital	Charlotte	North Carolina	28204	Recruiting
Wake Forest University Health Sciences	Winston-Salem	North Carolina	27157	Withdrawn
Randall Children's Hospital	Portland	Oregon	97227	Recruiting
Penn State Milton S. Hershey Medical Center and Children's Hospital	Hershey	Pennsylvania	17033	Recruiting
Medical University of South Carolina	Charleston	South Carolina	29425	Recruiting
Dell Children's Blood and Cancer Center	Austin	Texas	78723	Recruiting
Virginia Commonwealth University	Richmond	Virginia	23284	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT05489887, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Jun 30, 2026 · Synced Jul 24, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05489887 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →